Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-14 of 14
Keywords: Phosphate
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2014) 128 (1-2): 1–10.
Published Online: 08 November 2014
...Kosaku Nitta; Nobuo Nagano; Ken Tsuchiya Fibroblast growth factor-23 (FGF23) is a bone-derived hormone that regulates phosphate and 1,25-hydroxyvitamin D [1,25(OH) 2 D] metabolism. FGF23 binds to FGF receptor 1 with its coreceptor Klotho and maintains serum phosphate levels within the normal range...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2014) 126 (1): 1–7.
Published Online: 11 January 2014
.... Chronic kidney disease Phosphate Nutrition The kidney plays an essential role in nutrient homeostasis and electrolyte and fluid control. Thus, the presence of reduced kidney function and development of chronic kidney disease (CKD) requires specific dietary adaptations. Some of these adaptations...
Journal Articles
Subject Area:
Nephrology
Indranil Dasgupta, Rukshana Shroff, David Bennett-Jones, Gary McVeigh, for the NICE Hyperphosphataemia Guideline Development Group
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2013) 124 (1-2): 1–9.
Published Online: 06 September 2013
... that hyperphosphataemia in CKD is associated with increased mortality. Furthermore, the use of phosphate binders in dialysis patients is associated with significantly lower mortality. The UK Renal Registry data show significant underachievement of phosphate targets in dialysis patients. It is believed to be due to wide...
Journal Articles
Subject Area:
Nephrology
Geoffrey A. Block, Martha S. Persky, Beth M. Shamblin, Marissa F. Baltazar, Bhupinder Singh, Amit Sharma, Pablo Pergola, Gerard Smits, Maria C. Comelli
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2013) 123 (1-2): 93–101.
Published Online: 22 June 2013
...Geoffrey A. Block; Martha S. Persky; Beth M. Shamblin; Marissa F. Baltazar; Bhupinder Singh; Amit Sharma; Pablo Pergola; Gerard Smits; Maria C. Comelli Background/Aims: Serum phosphate (P) has been linked to adverse events in patients with chronic kidney disease. Salivary phosphate (Psal) has been...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2012) 120 (Suppl. 1): c175–c210.
Published Online: 01 September 2012
... phosphate, adjusted calcium, parathyroid hormone, bicarbonate and total cholesterol. In addition longitudinal analyses were performed (2000–2010) to show changes in achievement of clinical performance measures over time. Results: Fiftysix percent of HD and 69% of PD patients achieved a phosphate within...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2011) 119 (Suppl. 2): c179–c214.
Published Online: 26 August 2011
.... The biochemical variables studied were phosphate, adjusted calcium, parathyroid hormone, bicarbonate and total cholesterol. In addition longitudinal analyses were performed (2000–2009) to show changes in achievement of clinical performance measures over time. Results: Sixtyone percent of HD and 70% of PD patients...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2011) 118 (Suppl. 1): c145–c152.
Published Online: 06 May 2011
... from any ideas, methods, instructions or products referred to in the content or advertisements. mineral bone disorders chronic kidney disease parathyroid hormone calcium phosphate phosphate binder 24 05 2010 6 12 2010 6 5 2011 Nephron Clin Pract 2011;118(suppl 1):c145...
Journal Articles
Subject Area:
Nephrology
Ana L.E. Cancela, Rodrigo B. Oliveira, Fabiana G. Graciolli, Luciene M. dos Reis, Fellype Barreto, Daniela V. Barreto, Lilian Cuppari, Vanda Jorgetti, Aluizio B. Carvalho, Maria Eugênia Canziani, Rosa M.A. Moysés
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2010) 117 (1): c74–c82.
Published Online: 04 August 2010
... in chronic kidney disease (CKD), and the influence of current CKD-mineral and bone disorder (MBD) therapies on serum FGF23 levels is still under investigation. Methods: In this post-hoc analysis of a randomized clinical trial, phosphate binders and calcitriol were washed out of 72 hemodialysis patients who...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2010) 115 (Suppl. 1): c187–c238.
Published Online: 31 March 2010
...) cohorts in 2008. The biochemical variables studied were phosphate, adjusted calcium, calcium phosphate product, parathyroid hormone, bicarbonate, total cholesterol and HbA1c. In addition, longitudinal analyses were performed (2000–2008) to show changes in achievement of clinical performance measures over...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2010) 114 (4): c268–c276.
Published Online: 20 January 2010
... < 0.001) and 7.7% of patients had at least one serum calcium value above the normal range. Serum phosphate increased from 1.50 to 1.57 mmol/l (p < 0.001) and phosphate rose above 1.8 mmol/l in 21.5% of patients. Serum calcitriol increased significantly from 20.6 ng/l at baseline to 31.1 ng/l during...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2009) 111 (Suppl. 1): c185–c225.
Published Online: 26 March 2009
.... The biochemical variables studied were phosphate, adjusted calcium, parathyroid hormone, bicarbonate and total cholesterol. In addition longitudinal analyses were performed (2000–2007) to show changes in achievement of clinical performance measures over time. Results: Serum phosphate was between 1.1–1.8 mmol/L...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2008) 109 (3): c173–c180.
Published Online: 25 July 2008
...Belinda Morey; Rebecca Walker; Andrew Davenport Background/Aim: A randomized controlled trial was conducted involving 67 stable adult haemodialysis patients with hyperphosphataemia. The objective was to determine the effect of monthly dietetic consultations on patients’ serum phosphate...
Journal Articles
Subject Area:
Nephrology
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2005) 101 (3): c155–c160.
Published Online: 15 July 2005
... for albumin), albumin, phosphate, parathyroid hormone. Associations with RLS were analysed by univariate and multivariate logistic regression. Results: Data relating to 277 of 295 patients who had been attending for regular HHD for >3 months were collected. RLS was present in 127 (45.8%). 82 (29.6%), 27...
Journal Articles
Subject Area:
Nephrology
A.J. Hutchison, B. Maes, J. Vanwalleghem, G. Asmus, E. Mohamed, R. Schmieder, W. Backs, R. Jamar, A. Vosskühler
Journal:
Nephron Clinical Practice
Nephron Clinical Practice (2005) 100 (1): c8–c19.
Published Online: 04 April 2005
... of morbidity and mortality in dialysis patients. Existing oral phosphate binders have not permitted control of serum phosphate within currently accepted guidelines. This study compares lanthanum carbonate with calcium carbonate for control of serum phosphate in hemodialysis patients. Methods: In this European...